Mark Carthy

Mark Carthy is an accomplished professional with extensive experience in venture capital, private equity, and commercial real estate, currently serving as Managing Partner at Orion Equity Partners, LLC since January 2008. With a notable role as Chairman at Antolrx, Inc. since March 2014, Mark Carthy has been instrumental in drug discovery and development. Additional positions include membership with Walnut Ventures and Mass Medical Angels, the latter focusing on life science and healthcare investments. Mark serves as an advisor on the Industrial Advisory Board for the Chemical Engineering Department at University College Dublin. Previous board memberships include the Earthwatch Institute and Rexahn Pharmaceuticals, highlighting a commitment to both environmental and healthcare advancements. Educational credentials include an MBA from Harvard Business School and a Master of Science in Chemical Engineering from Missouri University of Science and Technology, complemented by a Bachelor of Engineering in Chemical Engineering from UCD.